Cargando…

Abnormal development of NG2(+)PDGFRα(+) neural progenitor cells leads to neonatal hydrocephalus in a ciliopathy mouse model

Hydrocephalus is a common neurological disorder leading to expansion of the cerebral ventricles and is associated with significant morbidity and mortality. Most neonatal cases are of unknown etiology and are likely to display complex inheritance involving multiple genes and environmental factors. Id...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Calvin S., Vogel, Timothy W., Zhang, Qihong, Seo, Seongjin, Swiderski, Ruth E., Moninger, Thomas O., Cassell, Martin D., Thedens, Daniel R., Keppler-Noreuil, Kim M., Nopoulos, Peggy, Nishimura, Darryl Y., Searby, Charles C., Bugge, Kevin, Sheffield, Val C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684048/
https://www.ncbi.nlm.nih.gov/pubmed/23160237
http://dx.doi.org/10.1038/nm.2996
Descripción
Sumario:Hydrocephalus is a common neurological disorder leading to expansion of the cerebral ventricles and is associated with significant morbidity and mortality. Most neonatal cases are of unknown etiology and are likely to display complex inheritance involving multiple genes and environmental factors. Identifying molecular mechanisms for neonatal hydrocephalus and developing non-invasive treatment modalities are high priorities. Here we employ a hydrocephalic mouse model of the human ciliopathy Bardet-Biedl Syndrome (BBS) and identify a role for neural progenitors in the pathogenesis of neonatal hydrocephalus. We found that hydrocephalus in this mouse model is caused by aberrant PDGFRα signaling, resulting in increased apoptosis and impaired proliferation of NG2(+)PDGFRα(+) neural progenitors. Targeting this pathway with lithium treatment rescued NG2(+)PDGFRα(+) progenitor cell proliferation in BBS mutant mice, reducing ventricular volume. Our findings demonstrate that neural progenitors are critical in the pathogenesis of neonatal hydrocephalus and we identify novel therapeutic targets for this common neurological disorder.